CU20100253A7 - COMPOSITIONS AND PROCESS-365 - Google Patents
COMPOSITIONS AND PROCESS-365Info
- Publication number
- CU20100253A7 CU20100253A7 CU20100253A CU20100253A CU20100253A7 CU 20100253 A7 CU20100253 A7 CU 20100253A7 CU 20100253 A CU20100253 A CU 20100253A CU 20100253 A CU20100253 A CU 20100253A CU 20100253 A7 CU20100253 A7 CU 20100253A7
- Authority
- CU
- Cuba
- Prior art keywords
- formula
- compound
- preparation
- space
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 abstract 1
- 229940095064 tartrate Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se estipula un proceso para la preparación de un compuesto de fórmula I, ESPACIO PARA LA PRIMERA FÓRMULA el uso de dicho proceso en la preparación de un compuesto de fórmula 5 ESPACIO PARA LA SEGUNDA FÓRMULA o de una de sus sales de fosfato, sulfato, sulfato ácido, maltato, citrato, tartrato o fumarato, y el uso de la sal de fumarato en una composición para usar en terapia.A process for the preparation of a compound of formula I, SPACE FOR THE FIRST FORMULA is stipulated the use of said process in the preparation of a compound of formula 5 SPACE FOR THE SECOND FORMULA or of one of its phosphate, sulfate, sulfate salts acid, maltate, citrate, tartrate or fumarate, and the use of fumarate salt in a composition for use in therapy.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100253A CU20100253A7 (en) | 2010-12-20 | 2010-12-20 | COMPOSITIONS AND PROCESS-365 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20100253A CU20100253A7 (en) | 2010-12-20 | 2010-12-20 | COMPOSITIONS AND PROCESS-365 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20100253A7 true CU20100253A7 (en) | 2011-11-15 |
Family
ID=45000172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU20100253A CU20100253A7 (en) | 2010-12-20 | 2010-12-20 | COMPOSITIONS AND PROCESS-365 |
Country Status (1)
| Country | Link |
|---|---|
| CU (1) | CU20100253A7 (en) |
-
2010
- 2010-12-20 CU CU20100253A patent/CU20100253A7/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201000225A (en) | COMPOSITION AND PROCESS - 356. | |
| AR117799A2 (en) | 7-CYCLOPENTIL-2- (5-PIPERAZIN-1-IL-PYRIDIN-2-IL-AMINO) -7H-PIRROLO- [2,3-D] -PYRIMIDIN-6- ACID DIMETHYL-AMIDE SALT (S) CARBOXYL AND PROCESSES FOR ITS PREPARATION | |
| NZ607794A (en) | N-acylsulfonamide apoptosis promoters | |
| BR112014003237A2 (en) | indazole compounds, compositions and methods of use | |
| EA201100030A1 (en) | PYRAZOL COMPOUNDS 436 | |
| BR112013020767A2 (en) | compositions comprising alpha-ketocarboxylic peroxy acid and methods for the production and use thereof | |
| EA201700230A1 (en) | DETERMINED AMINOPYRIDINES, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR APPLICATION | |
| CL2009000316A1 (en) | Compounds derived from benzomorphane urea and their salts, inhibitors of the enzyme 11-beta-hydroxysteroid dehydrogenase; preparation procedure; pharmaceutical composition; and use for the treatment or prevention of metabolic disorders. | |
| BR112012026767A2 (en) | compound, pharmaceutically acceptable salt of a compound, pharmaceutical composition, method for treating or preventing disorders, and use of a compound or salt | |
| MX358345B (en) | AN AMORPHY FORM AND A GENZ 112638 HEMITARTRATE CRYSTALLINE AS A GLUCOSILCERAMIDE SYNTHEASE INHIBITOR. | |
| EA201201648A1 (en) | SGC STIMULATORS | |
| GEP20166432B (en) | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh | |
| CR20130023A (en) | PIRAZOLO [1,5-A] PYRIMIDINS FOR ANTIVIRAL TREATMENT | |
| PH12014501277A1 (en) | Kinase inhibitors | |
| AR107864A1 (en) | ACID 7a, 11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO AND PHARMACEUTICAL COMPOSITIONS | |
| EA201190296A1 (en) | DISAHARINOVAYA, DIFUMAROVO-acidic, CI-1-hydroxy-2-naphthoic acid and MONOBENZOYNO-acid salt-4- (dimethylamino) butyl-2- (4 - ((2-AMINO-4-METHYL-6- (pentylamino) pyrimidine -5-IL) METHYL) PHENYL) ACETATE | |
| BR112013029640A2 (en) | pyridine and pyrazine derivatives | |
| AR079050A1 (en) | BENZOIMIDAZOLIC COMPOUNDS AND THEIR USES | |
| NI201800051A (en) | IMIDAZO [4, 5-C] QUINOLIN-2-ONA COMPOUNDS AND ITS USE IN THE TREATMENT OF CANCER | |
| BR112012019561A2 (en) | hetarylamino naphthyridines | |
| ECSP11011224A (en) | DERIVATIVES OF TIADIAZOLES AND OXADIAZOLS, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY | |
| BR112013003722A2 (en) | care products and methods of use and manufacture | |
| CU24330B1 (en) | ACID DERIVATIVES 4 - ((1,1) BIFENIL-4-IL) -3- (3-PHOSPHONOPROPANAMIDE) BUTANOIC, ASSETS AS NEP INHIBITORS (NEUTRAL ENDOPEPTIDASE) | |
| CR20140053A (en) | DEOXICOLIC ACID FORMULATIONS AND SALTS OF THE SAME | |
| PH12014501278A1 (en) | Kinase inhibitors |